Specialties
Medicinal
Cannabis
You can't advertise the medicine.
Most operators stopped there.
The obvious channels closed, and most operators answered by publishing less until the website became a brochure nobody reads.
We write the material that still works, for licensed suppliers and prescribing clinics.
Get the marketing risk auditA $2,000 audit. $1,499 for exhibitors this week.
The category grew 26% in a year.
Approvals under the Special Access Scheme Category B rose roughly 26% between 2024 and 2025. More prescribers writing, more patients approved, more product moving.
Over the same period the ways you're permitted to talk about it narrowed. Most of the sector went quieter.
Two audiences, one prohibition
A supplier and a clinic have different problems
One can't create demand for what it makes. The other can't describe what it prescribes. Most agencies arrive treating that as a single brief.
Suppliers, growers, importers and sponsors
Someone else owns your demand
Clinics and distributors hold the patient relationship. You carry the licence, the facility and the capital, and the account that made your year can leave on a phone call.
Four good days a year
The conference works, which is how it quietly became the entire plan. A prescriber who met you in March has forgotten you by June.
Exposure you didn't create
A distributor writes a promotional post. As sponsor, the liability can travel back to you, and you find out when somebody sends you a screenshot.
Clinics and prescribing services
The funnel closed
Eligibility quizzes, condition dropdowns, find out if you qualify. Current guidance treats those mechanics as advertising the medicine, so the thing that built the practice is the thing that can't run.
Paid stopped being yours
Restrictions arrive with no warning and no appeal, on creative that ran fine last month. That's not a channel you can put a payroll on.
Your best pages are your riskiest pages
Your condition pages bring in most of the enquiries and carry most of the exposure. Taking them down reads as switching off your own pipeline, so nobody touches them.
Telehealth prescribing service · NATIONAL
Rebuilding acquisition for a prescribing service after the guidance moved
The site was built around eligibility and condition selection. Two ad accounts were restricted inside six months, and the pages carrying the exposure were the pages carrying the traffic.
We mapped it first, then rebuilt in an order that put the replacement in front of search before anything came down.
Substitute terms, acronyms, imagery, page titles, the booking flow, the business name. 47 findings, 9 rated critical. The client's own team cleared a third of them inside a fortnight without needing us.
Remediation usually costs a practice its enquiries. We published and indexed the replacement content, moved the internal links, then retired the exposed pages. 86% of enquiry volume held through the change.
The practice had never built anything for referring GPs. 11 referring practitioners inside 5 months, and a source of patients that doesn't depend on an ad account staying live.
Five services.
One compliance
framework.
Everything is read against the perimeter before it reaches you, so sign-off is a check rather than a negotiation.
Start here
Marketing Risk and Website Pipeline Audit
Find out which pages create risk and which ones lose you enquiries, before committing to any spend.
Website and Page Copy
Site and landing page copy that describes the condition, the service and the practitioner without pointing anyone at a medicine.
Social and Professional Audience Content
Public-feed content that holds up, and gated material for the professional audience where the exemption genuinely applies.
Email, Retention and Reactivation
Keeping the people you've already paid to acquire. Email returns around $36 for every dollar spent, and in a repeat-consultation or repeat-order business that's the cheapest revenue available.
Referral and Trade Positioning
Becoming the supplier a distributor names first, or the practice a GP refers to without being asked.
Every page rated,
in the order
to fix it.
Exposure is invisible from the inside. So is the drop-off.
A page reads fine to whoever commissioned it, and very differently to a regulator, a referring GP, and a first-time visitor deciding whether to fill in the form. The audit reads every page from all three angles, with a severity rating and an owner against each finding.
14.6% vs 1.7%
Organic search leads close at around 14.6%. Paid and outbound close at around 1.7%. The channel that's harder to buy is the one that converts.
Marketing Risk and Website Pipeline Audit
$2,000 ex GST. $1,699 for conference attendees, $1,499 for stallholders and exhibitors, until Friday 14 August.
What you'll know before you spend another dollar
- Every page rated from critical down to worth tidying, with an owner against each finding
- Where a first-time visitor stops instead of getting in touch
- How your copy, imagery and booking flow read against the prohibition on indirect references
- The searches you're losing, and the ones worth leaving alone
Prepared individually and delivered within five working days. This is a marketing and advertising risk review, not legal advice. Unsubscribe in one click, any time.
Prefer to talk first?
Skip the audit and talk to us directly.
At the conference?
Ivan Lusica, our Co-Founder and APAC Managing Director, is there all week. Book fifteen minutes.
Letter from the APAC Managing Director
The regulatory shifts your competitors haven't read yet.
Written by Ivan Lusica, Co-Founder and Managing Director APAC, and a qualified lawyer. Guidance changes read properly, and what's worth knowing before it reaches you through somebody else. General commentary, not legal advice.
